ANNOUNCEMENT 23 Apr 2020
On 23 April 2020, the UK authorities announced imposing an export ban on 33 medicines due to prevent any medicine shortages following the Coronavirus outbreak.
NUMBER OF INTERVENTIONS
The UK Government, “Medicines that cannot be parallel exported from the UK”, Available at: https://www.gov.uk/government/publications/medicines-that-cannot-be-parallel-exported-from-the-uk#history
The UK Government, List of medicines that cannot be parallel exported from the UK, last updated 23 April 2020: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/880831/Medicines_that_cannot_be_parallel_exported_from_the_UK_23.csv/preview
On 23 April 2020, the Department of Health and Social Care of the United Kingdom added 33 medicines to the list of medicines that cannot be parallel exported from the UK. The decision is taken to prevent any medicine shortages in the battle against the Coronavirus outbreak.
The UK authorities noted that: “Parallel export of a medicine on the list is considered a breach of regulation 43(2) of the Human Medicines Regulations 2012 and a contravention of the wholesale dealer license and may lead to regulatory action by the Medicines and Healthcare products Regulatory Agency (MHRA), which could include immediate suspension of the wholesale dealer license.”
Previously, on 1 April 2020, parallel export of 52 medicines was banned (see related state act).
On 15 June 2020, the UK authorities announced imposing an export ban on two pharmaceutical forms of dexamethasone (see related state act).